Trademark Search
Owners
AZURITY PHARMACEUTICALS, INC.
THYQUIDITY (LEVOTHYROXINE SODIUM) ORAL SOLUTION 100 MCG/5ML
no statement of use filed
on 08 May 2023
Last Applicant/ Owned by
SUITE 2000
WOBURN
MA
01801
Serial Number
90350942 filed on 01st Dec 2020
Registration Number
N/A
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
"(LEVOTHYROXINE SODIUM) ORAL SOLUTION 100 MCG/5ML"
pharmaceutical preparations for the treatment of hypothyroidism, thyroid hormone deficiency, myxedema and thyroid tumors The mark consists of a stylized infinity symbol followed by the text THYQUIDITY above the text "(LEVOTHYROXINE SODIUM)" above the text "100MGC/5ML". "(LEVOTHYROXINE SODIUM) ORAL SOLUTION 100 MCG/5ML" THYQUIDITY (LEVOTHYROXINE SODIUM) ORAL SOLUTION ONE HUNDRED MICRO GRAMS FIVERead More
pharmaceutical preparations for the treatment of hypothyroidism, thyroid hormone deficiency, myxedema and thyroid tumors
No 90350942
No Service/Collective Mark
No
No
No
No
No
No
No
No
No
24.17.12 -
Infinity symbol
The mark consists of a stylized infinity symbol followed by the text THYQUIDITY above the text "(LEVOTHYROXINE SODIUM)" above the text "100MGC/5ML".
| Status Date | Action Taken |
|---|---|
| 08th May 2023 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| 08th May 2023 | ABANDONMENT - NO USE STATEMENT FILED |
| 19th Oct 2022 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
| 06th Oct 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 04th Oct 2022 | SOU EXTENSION 1 GRANTED |
| 04th Oct 2022 | SOU EXTENSION 1 FILED |
| 04th Oct 2022 | TEAS EXTENSION RECEIVED |
| 03rd Aug 2022 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
| 05th Apr 2022 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| 08th Feb 2022 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
